Request Deal Involvement

Northpond Ventures led a $85m Series B funding round in Kyverna Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Hogan Lovells

legal advisors

Hogan Lovells

Greig Communications

pr advisors

Greig Communications

Willkie Farr & Gallagher

legal advisors

Willkie Farr & Gallagher

or

Principals

LYFE CAPITAL

bidder

LYFE CAPITAL

HUDSON BAY CAPITAL MANAGEMENT LP

bidder

HUDSON BAY CAPITAL MANAGEMENT LP

NORTHPOND VENTURES

bidder

NORTHPOND VENTURES

VIDA VENTURES

bidder

VIDA VENTURES

CAM CAPITAL

bidder

CAM CAPITAL

GILEAD SCIENCES

bidder

GILEAD SCIENCES

WESTLAKE VILLAGE BIOPARTNERS

bidder

WESTLAKE VILLAGE BIOPARTNERS

KYVERNA THERAPEUTICS

target

KYVERNA THERAPEUTICS

RTW INVESTMENTS

bidder

RTW INVESTMENTS

INSIGHT PARTNERS LLC

bidder

INSIGHT PARTNERS LLC

HEALTHCOR PARTNERS MANAGEMENT

bidder

HEALTHCOR PARTNERS MANAGEMENT

INTELLIA THERAPEUTICS

bidder

INTELLIA THERAPEUTICS

ARGENTUM PEAK

bidder

ARGENTUM PEAK

JVEN CAPITAL

bidder

JVEN CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Northpond Ventures led a $85m Series B funding round in Kyverna Therapeutics.